BriaCell Therapeutics (BCTX) Live Share Price, Invest From India

BriaCell Therapeutics Stock Performance

as on August 28, 2026 at 6:07 am IST

Day's Low
Day's High
$3.60
Day's Price Range
$3.95
$3.71
2.96%
Downside
6.47%
Upside
52 Week's Low
52 Week's High
$2.60
52-Week Price Range
$14.68
$3.71
29.92%
Downside
295.69%
Upside

BriaCell Therapeutics share price movements today

Previous Close: $4.03
Open: $3.94
Volume: 622.5K
Market Cap: $32.8M
Day's Low - High: $3.60 - $3.95
52 Week Low - High: $2.60 - $14.68

BriaCell Therapeutics Historical Returns

1 Month Return: + 13.52 %
3 Month Return: + 11.02 %
1 Year Return: -46.97 %
3 Year Return: -99.64 %
5 Year Return: -99.58 %

BriaCell Therapeutics Stock Fundamentals & Key Indicators

Check BriaCell Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.8M

EPS (TTM)

-12.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.3

Industry PE ratio

-1.5979841897233202

PEG Ratio

-0.0013477007110070521

EBITDA

-31.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-147.92%

BriaCell Therapeutics Stock Valuation

Track how BriaCell Therapeutics P/E has moved over time to understand its valuation trends.

BriaCell Therapeutics in the last 5 years

Overview
Trends

Lowest (-25621.43x)

July 31, 2024

Industry (-1.60x)

July 31, 2025

Today (-0.16x)

July 31, 2025

Highest (-0.16x)

July 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.16x

BriaCell Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BriaCell Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
BriaCell Therapeutics	BUY	$32.8M	-99.58%	-0.3	0.00%	NA
Revolution Medicines	BUY	$45.3B	655.66%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$140.1B	173.75%	31.92	86.04%	NA
Moderna	BUY	$63.4B	-60.84%	-7.98	-12.57%	NA
Regeneron	BUY	$85.3B	22.84%	19.9	84.86%	0.44%

Stock Returns calculator for BriaCell Therapeutics Stock including INR - Dollar returns

The BriaCell Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

BriaCell Therapeutics investment value today

Current value as on today

₹53,198

Returns

-₹46,802

(-46.8%)

Returns from BriaCell Therapeutics Stock

-₹51,184 (-51.18%)

Dollar Impact

₹4,382 (+4.38%)

Analyst Recommendation on BriaCell Therapeutics Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for BriaCell Therapeutics. Average target price of $150

BriaCell Therapeutics Share Price Target

Get share price movements and forecasts by analysts on BriaCell Therapeutics.

What analysts predicted

97.53%UPSIDE

Target Price

$150

Current Price

$3.71

Analyzed by

5 Analysts

Target

$150.00

BriaCell Therapeutics target price $150, a slight upside of 97.53% compared to current price of $3.71. According to 5 analysts rating.

Indian Investors' Interest in BriaCell Therapeutics Stock

Search interest for BriaCell Therapeutics Stock has increased by 30% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 29, 2026 to August 28, 2026

Change:30% versus previous 30 day period

BriaCell Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Oct 2023	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	-	-	0	-	-	-
Operating Income	-8	-	-5	-5	-7	-6	-8	-8	-7	-7
EBITDA	-8	-9	-5	-5	-7	-6	-8	-8	-7	-7
Interest Expense	-	-	-	-	-	0	-	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	5	1	-1	-5	-6	-6	-8	-8	-7	-7
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	5	1	-1	-5	-6	-6	-8	-8	-7	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

BriaCell Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Jul 2017	Jul 2018	Jul 2019	Jul 2021	Jul 2022	Jul 2023	Jul 2024	Jul 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-	-	-	0
Operating Income	-3	-4	-6	-7	-15	-23	-33	-27
EBITDA	-3	-4	-6	-7	-26	-23	-4	-27
Interest Expense	-	0	0	0	0	-	-	0
Depreciation	-	0	0	0	0	0	0	0
Income Before Tax	-3	-5	-5	-13	-26	-20	-4	-26
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-3	-5	-5	-13	-26	-20	-4	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

BriaCell Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Oct 2023	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026
Net Income	5	1	-1	-5	-6	-6	-8	-8	-7	-7
Operating Cash Flow	-7	-4	-4	-6	-5	-7	-8	-7	-7	-7
Investing Cash Flow	-	0	0	0	0	0	-7	0	7	-16
Financing Cash Flow	-	-	4	11	5	14	13	-	27	0
Change in Cash	-6	-5	0	4	0	7	-1	-7	27	-22

BriaCell Therapeutics Annual Cash Flow

All numbers in Millions USD

	Jul 2017	Jul 2018	Jul 2019	Oct 2020	Jul 2021	Jul 2022	Jul 2023	Jul 2024	Jul 2025
Net Income	-3	-5	-5	-4	-13	-26	-20	-4	-26
Operating Cash Flow	-1	-4	-5	-1	-7	-12	-23	-24	-28
Investing Cash Flow	0	0	1	-	-	-	-	0	-7
Financing Cash Flow	2	5	2	1	64	-3	3	4	46
Change in Cash	1	0	0	0	57	-16	-19	-20	9

Global Institutional Holdings in BriaCell Therapeutics

Funds	Holdings
Cable Car Capital LLC	2.49%
Susquehanna International Group, LLP	0%
Iridian Asset Management LLC	0.75%
BlackRock Inc	0%
Federation des caisses Desjardins du Quebec	0.01%

See all

BriaCell Therapeutics News & Key Events

Insights on BriaCell Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 496.3% return, outperforming this stock by 543.3%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 33.7% return, outperforming this stock by 133.3%
NEGATIVE IMPACT
Price Dip
In the last 3 years, BCTX stock has moved down by -99.6%

About BriaCell Therapeutics

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Organisation	BriaCell Therapeutics
Headquarters	Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Industry	Biotechnology
CEO	Dr. William V. Williams FCPA, M.D.
E-voting on shares	Click here to vote

Key Management of BriaCell Therapeutics

Name	Title
Dr. Giuseppe Del Priore M.D., M.P.H.	Chief Medical Officer
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board
Dr. William V. Williams FCPA, M.D.	CEO, President & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.	CFO & Corporate Secretary
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer

FAQs

What is BriaCell Therapeutics share price today?

BriaCell Therapeutics share price today is $3.71 as on August 28, 2026 at 12:37 am IST. BriaCell Therapeutics share today touched a day high of $3.95 and a low of $3.60.

What is the 52 week high and 52 week low for BriaCell Therapeutics share?

BriaCell Therapeutics share touched a 52 week high of $14.68 on October 21, 2025 and a 52 week low of $2.60 on June 11, 2026. BriaCell Therapeutics stock price today i.e. August 28, 2026 at 12:37 am IST is trending at $3.71,which is 74.73% down from its 52 week high and 42.69% up from its 52 week low.

What is BriaCell Therapeutics's market capitalisation today?

BriaCell Therapeutics market capitalisation is $0.00T as on August 28, 2026 at 12:37 am IST.

How to invest in BriaCell Therapeutics Stock (BCTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for BriaCell Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BriaCell Therapeutics Shares that will get you 0.4043 shares as per BriaCell Therapeutics share price of $3.71 per share as on August 28, 2026 at 12:37 am IST.

What is the minimum amount required to buy BriaCell Therapeutics Stock (BCTX) from India?

Indian investors can start investing in BriaCell Therapeutics (BCTX) shares with as little as ₹95.53 or $1 (as of August 28, 2026 at 12:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹955.30 in BriaCell Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 28, 2026 at 12:39 am IST). Based on BriaCell Therapeutics share’s latest price of $3.71 as on August 28, 2026 at 12:37 am IST, you will get 2.6954 shares of BriaCell Therapeutics. Learn more about fractional shares .

What are the returns that BriaCell Therapeutics has given to Indian investors in the last 5 years?

BriaCell Therapeutics stock has given -99.58% share price returns and 30.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?